Danish
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

tyrosine/sarkom

Linket gemmes på udklipsholderen
Side 1 fra 25 resultater

Substituted phenylacrylonitrile compounds and compositions thereof for the treatment of disease

Kun registrerede brugere kan oversætte artikler
Log ind / Tilmeld
1. INTRODUCTION The present invention relates to novel compounds capable of modulating and/or regulating tyrosine kinase signal transduction. The Applicants have demonstrated that the murine fetal liver kinase 1 (FLK-1) receptor and its non-murine counterparts, including the human Kinase

Compounds for the treament of disorders related to vasculogenesis and/or angiogenesis

Kun registrerede brugere kan oversætte artikler
Log ind / Tilmeld
1. INTRODUCTION The present invention relates to novel compounds capable of modulating and/or regulating tyrosine kinase signal transduction. The Applicants have demonstrated that the murine fetal liver kinase 1 (FLK-1) receptor and its non-murine counterparts, including the human Kinase

Compounds for the treatment of disorders related to vasculogenesis and/or angiogenesis

Kun registrerede brugere kan oversætte artikler
Log ind / Tilmeld
1. INTRODUCTION The present invention relates to novel compounds capable of modulating and/or regulating tyrosine kinase signal transduction. The Applicants have demonstrated that the murine fetal liver kinase 1 (FLK-1) receptor and its non-murine counterparts, including the human Kinase

Compounds for the treatment of disorders related to vasculogenesis and/or angiogenesis

Kun registrerede brugere kan oversætte artikler
Log ind / Tilmeld
1. Introduction The present invention relates to novel compounds capable of modulating and/or regulating tyrosine kinase signal transduction. The Applicants have demonstrated that the murine fetal liver kinase 1 (FLK-1) receptor and its non-murine counterparts, including the human Kinase

Quinazoline compounds and compositions thereof for the treatment of disease

Kun registrerede brugere kan oversætte artikler
Log ind / Tilmeld
1. INTRODUCTION The present invention relates to novel compounds capable of modulating and/or regulating tyrosine kinase signal transduction. The Applicants have demonstrated that the murine fetal liver kinase 1 (FLK-1) receptor and its non-murine counterparts, including the human Kinase
FIELD OF INVENTION This invention provides methods of treating, reducing the incidence of, and inhibiting metastasis formation of carcinomas, sarcomas, Epstein-Barr virus-induced malignancies, B cell proliferative disorders, and mast cell activation disorders, comprising administering to a subject a

Method of producing hepatocycte growth factor/scatter factor and related cell lines

Kun registrerede brugere kan oversætte artikler
Log ind / Tilmeld
BACKGROUND OF THE INVENTION Hepatocyte growth factor (HGF) was first purified from human and rabbit plasma and rat platelets on the basis of its ability to stimulate mitogenesis of rat hepatocytes. (E. Gohda et al., J. Clin. Invest 81: 414 (1988); R. Zarnegar and G. Michalopoulos, Cancer Res. 49:

Class of arylamide compounds useful as inhibitors of c-fms kinase

Kun registrerede brugere kan oversætte artikler
Log ind / Tilmeld
CROSS-REFERENCE TO RELATED APPLICATIONS Not applicable. BACKGROUND OP THE INVENTION 1. Field of the Invention The invention relates to novel compounds that function as protein tyrosine kinase inhibitors. More particularly, the invention relates to novel arylamide and hetereoarylamide compounds that

Inhibitors of c-fms kinase

Kun registrerede brugere kan oversætte artikler
Log ind / Tilmeld
BACKGROUND OF THE INVENTION The invention relates to novel compounds that function as protein tyrosine kinase inhibitors. More particularly, the invention relates to novel compounds that function as inhibitors of c-fms kinase. Protein kinases are enzymes that serve as key components of signal

Inhibitors of c-fms kinase

Kun registrerede brugere kan oversætte artikler
Log ind / Tilmeld
BACKGROUND OF THE INVENTION The invention relates to novel compounds that function as protein tyrosine kinase inhibitors. More particularly, the invention relates to novel compounds that function as inhibitors of c-fms kinase. Protein kinases are enzymes that serve as key components of signal

Inhibitors of c-fms kinase

Kun registrerede brugere kan oversætte artikler
Log ind / Tilmeld
BACKGROUND OF THE INVENTION The invention relates to novel compounds that function as protein tyrosine kinase inhibitors. More particularly, the invention relates to novel compounds that function as inhibitors of c-fms kinase. Protein kinases are enzymes that serve as key components of signal

Inhibitors of c-fms kinase

Kun registrerede brugere kan oversætte artikler
Log ind / Tilmeld
BACKGROUND OF THE INVENTION The invention relates to novel compounds that function as protein tyrosine kinase inhibitors. More particularly, the invention relates to novel compounds that function as inhibitors of c-fms kinase. Protein kinases are enzymes that serve as key components of signal

Inhibitors of C-FMS kinase

Kun registrerede brugere kan oversætte artikler
Log ind / Tilmeld
BACKGROUND OF THE INVENTION The invention relates to novel compounds that function as protein tyrosine kinase inhibitors. More particularly, the invention relates to novel compounds that function as inhibitors of c-fms kinase. Protein kinases are enzymes that serve as key components of signal

Inhibitors of c-fms kinase

Kun registrerede brugere kan oversætte artikler
Log ind / Tilmeld
BACKGROUND OF THE INVENTION The invention relates to novel compounds that function as protein tyrosine kinase inhibitors. More particularly, the invention relates to novel compounds that function as inhibitors of c-fms kinase. Protein kinases are enzymes that serve as key components of signal

Inhibitors of C-FMS kinase

Kun registrerede brugere kan oversætte artikler
Log ind / Tilmeld
SEQUENCE LISTING The instant application contains a Sequence Listing which has been submitted in ASCII format via EFS-Web and is hereby incorporated by reference in its entirety. Said ASCII copy, created on Jul. 23, 2013, is named PRD2659USDIV3_SL.txt and is 825 bytes in size. BACKGROUND OF THE
Deltag i vores
facebook-side

Den mest komplette database med medicinske urter understøttet af videnskab

  • Arbejder på 55 sprog
  • Urtekurer, der understøttes af videnskab
  • Urtegenkendelse ved billede
  • Interaktivt GPS-kort - tag urter på stedet (kommer snart)
  • Læs videnskabelige publikationer relateret til din søgning
  • Søg medicinske urter efter deres virkninger
  • Organiser dine interesser og hold dig opdateret med nyhedsundersøgelser, kliniske forsøg og patenter

Skriv et symptom eller en sygdom, og læs om urter, der kan hjælpe, skriv en urt og se sygdomme og symptomer, den bruges mod.
* Al information er baseret på offentliggjort videnskabelig forskning

Google Play badgeApp Store badge